Tofacitinib for juvenile idiopathic arthritis - Authors' reply
- PMID: 35569465
- DOI: 10.1016/S0140-6736(22)00837-6
Tofacitinib for juvenile idiopathic arthritis - Authors' reply
Comment on
-
Tofacitinib for juvenile idiopathic arthritis.Lancet. 2022 May 14;399(10338):1865-1866. doi: 10.1016/S0140-6736(22)00836-4. Lancet. 2022. PMID: 35569464 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
